ProShare Advisors’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $26.5M | Buy |
|
|||||
2025
Q1 | $25.1M | Buy |
|
|||||
2024
Q4 | $24M | Buy |
|
|||||
2024
Q3 | $22.8M | Sell |
|
|||||
2024
Q2 | $23.7M | Buy |
|
|||||
2024
Q1 | $21.9M | Sell |
|
|||||
2023
Q4 | $23.4M | Sell |
|
|||||
2023
Q3 | $29.5M | Sell |
|
|||||
2023
Q2 | $34M | Sell |
|
|||||
2023
Q1 | $38.5M | Buy |
|
|||||
2022
Q4 | $43M | Sell |
|
|||||
2022
Q3 | $37M | Sell |
|
|||||
2022
Q2 | $48.6M | Sell |
|
|||||
2022
Q1 | $65.8M | Sell |
|
|||||
2021
Q4 | $75.1M | Buy |
|
|||||
2021
Q3 | $43M | Buy |
|
|||||
2021
Q2 | $38.8M | Buy |
|
|||||
2021
Q1 | $30.1M | Buy |
|
|||||
2020
Q4 | $29.1M | Buy |
|
|||||
2020
Q3 | $26.9M | Sell |
|
|||||
2020
Q2 | $30.8M | Buy |
|
|||||
2020
Q1 | $26.3M | Sell |
|
|||||
2019
Q4 | $47.9M | Buy |
|
|||||
2019
Q3 | $35.8M | Buy |
|
|||||
2019
Q2 | $41.6M | Sell |
|
|||||
2019
Q1 | $48.6M | Buy |
|
|||||
2018
Q4 | $49.8M | Buy |
|
|||||
2018
Q3 | $44.7M | Sell |
|
|||||
2018
Q2 | $42.8M | Sell |
|
|||||
2018
Q1 | $46.2M | Buy |
|
|||||
2017
Q4 | $44.9M | Buy |
|
|||||
2017
Q3 | $30.2M | Buy |
|
|||||
2017
Q2 | $25.9M | Sell |
|
|||||
2017
Q1 | $28M | Sell |
|
|||||
2016
Q4 | $27.6M | Buy |
|
|||||
2016
Q3 | $22.6M | Sell |
|
|||||
2016
Q2 | $32M | Sell |
|
|||||
2016
Q1 | $27.3M | Sell |
|
|||||
2015
Q4 | $42.4M | Buy |
|
|||||
2015
Q3 | $39.9M | Buy |
|
|||||
2015
Q2 | $40.9M | Sell |
|
|||||
2015
Q1 | $49.6M | Sell |
|
|||||
2014
Q4 | $49.1M | Buy |
|
|||||
2014
Q3 | $38.3M | Sell |
|
|||||
2014
Q2 | $41.5M | Sell |
|
|||||
2014
Q1 | $47.6M | Buy |
|
|||||
2013
Q4 | $42.9M | Buy |
|
|||||
2013
Q3 | $22.3M | Sell |
|
|||||
2013
Q2 | $34.4M | Buy |
|